Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

NCT00198510 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitreous Hemorrhage
Diabetic Retinopathy

Interventions

DRUG: Vitrase
DRUG: Vitrase
DRUG: Vitrase

Sponsor

Bausch & Lomb Incorporated